A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime
Other Hematopoietic | Pediatrics | Sickle Cell Disorders
What is the purpose of this trial?
The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.
- Trial withNO FUNDING
- Start Date05/17/2022
- End Date12/31/2026
- Last Updated05/18/2022
- Study HIC#2000021396